Human Vaccines & Immunotherapeutics, 2021 Viruses have spent millions of years perfecting one remarkable ability: delivering genetic information into cells. At NIMVEC, we harness natural precision to develop next-generation viral vector technologies for gene and immune-based therapies. We aim to unlock new approaches to treating autoimmune conditions, genetic disorders, chronic inflammatory diseases and possibly cancer—transforming nature’s most efficient delivery system into tomorrow’s therapeutic platform.
